Alcon, the eyecare division of Novartis, said it would investigate claims that it used fake clinical trials to bribe doctors in China, the latest in what has become a steady stream of corruption allegations against mostly foreign pharmaceutical companies in China.
http://www.ft.com/cms/s/0/5851e1a2-1f73-11e3-aa36-00144feab7de.html#axzz2f97czlYi
No comments:
Post a Comment